|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 403/14 | |
| C07D 401/14 | |||
| C07D 417/14 | |||
| A61K 31/4025 | |||
| A61K 31/4178 | |||
| A61K 31/4184 | |||
| A61K 31/4196 | |||
| A61K 31/4439 | |||
| A61P 31/14 |
| (11) | Number of the document | 2337781 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10724656.3 |
| Date of filing the European patent application | 2010-06-10 | |
| (97) | Date of publication of the European application | 2011-06-29 |
| (45) | Date of publication and mention of the grant of the patent | 2014-07-23 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/038077 |
| Date | 2010-06-10 |
| (87) | Number | WO 2010/144646 |
| Date | 2010-12-16 |
| (30) | Number | Date | Country code |
| 186291 P | 2009-06-11 | US | |
| 242836 P | 2009-09-16 | US | |
| 243596 P | 2009-09-18 | US |
| (72) |
RANDOLPH, John T., US
DEGOEY, David A., US
KATI, Warren M., US
HUTCHINS, Charles W., US
DONNER, Pamela L., US
KRUEGER, Allan C., US
MOTTER, Christopher E., US
NELSON, Lissa T., US
PATEL, Sachin V., US
MATULENKO, Mark A., US
KEDDY, Ryan G., US
JINKERSON, Tammie K., US
HUTCHINSON, Douglas K., US
FLENTGE, Charles A., US
WAGNER, Rolf, US
MARING, Clarence J., US
TUFANO, Michael D., US
BETEBENNER, David A., US
ROCKWAY, Todd W., US
LIU, Dachun, US
PRATT, John K., US
SARRIS, Kathy, US
WOLLER, Kevin R., US
WAGAW, Seble H., US
CALIFANO, Jean C., US
LI, Wenke, US
CASPI, Daniel.D., US
BELLIZZI, Mary, E., US
GAO, Yi, US
|
| (73) |
AbbVie Bahamas Ltd.,
Sassoon House Shirley Street & Victoria Avenue, New Providence, Nassau,
BS
|
| (54) | ANTI-VIRAL COMPOUNDS TO TREAT HCV INFECTION |
| ANTI-VIRAL COMPOUNDS TO TREAT HCV INFECTION |